Publication:
Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia (CML).

Simple item page
dc.contributor.authorsEksioglu-Demiralp, E; Bizargity, P; Adiguzel, C; Ozilhan, G; Bayik, M
dc.date.accessioned2022-03-12T15:58:39Z
dc.date.accessioned2026-01-11T15:13:39Z
dc.date.available2022-03-12T15:58:39Z
dc.date.issued2004
dc.identifier.doi10.1182/blood.V104.11.4673.4673
dc.identifier.issn0006-4971
dc.identifier.urihttps://hdl.handle.net/11424/224125
dc.identifier.wosWOS:000225127701003
dc.language.isoeng
dc.publisherAMER SOC HEMATOLOGY
dc.relation.ispartofBLOOD
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleImatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia (CML).
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage252B
oaire.citation.issue11
oaire.citation.startPage252B
oaire.citation.titleBLOOD
oaire.citation.volume104

Files

Collections

Araştırma Çıktıları